These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7857106)

  • 1. [Delayed clearance of methotrexate in a patient with malignant lymphoma who developed renal failure].
    Wakita A; Komatsu H; Banno S; Nitta M; Nagai H; Uchida T; Murase T; Nakahara Y; Tanaka M
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):285-8. PubMed ID: 7857106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate-induced renal failure and ineffectiveness of peritoneal dialysis.
    Ahmad S; Shen FH; Bleyer WA
    Arch Intern Med; 1978 Jul; 138(7):1146-7. PubMed ID: 666479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate clearance by high-flux hemodialysis and peritoneal dialysis: a case report.
    Murashima M; Adamski J; Milone MC; Shaw L; Tsai DE; Bloom RD
    Am J Kidney Dis; 2009 May; 53(5):871-4. PubMed ID: 19339090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of plasma exchange in methotrexate removal in a patient with osteosarcoma and acute renal insufficiency.
    Cecyn KZ; Lee J; Oguro T; Petrilli AS; Bordin JO
    Am J Hematol; 2003 Mar; 72(3):209-11. PubMed ID: 12605394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute renal failure after high-dose methotrexate therapy in a patient with ileostomy.
    ASADA D; MATSUBARA H; KATO I; OSADA K; URYU K; TOKUMASU M; UMEDA K; WATANABE K; ADACHI S; OKAMOTO S; UEMOTO S; NAKAHATA T
    Rinsho Ketsueki; 2009 Nov; 50(11):1607-11. PubMed ID: 20009434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early recognition of patients with decreased methotrexate clearance following high-dose methotrexate infusion therapy.
    Ikeda H; Kihira K; Kuwata N; Arai S; Kimura Y; Miyake K; Kitaura T; Fujimura K; Kuramoto A; Fukuchi H
    Hiroshima J Med Sci; 1996 Jun; 45(2):57-62. PubMed ID: 8810132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe complications after intrathecal methotrexate (MTX) for treatment of primary central nervous system lymphoma (PCNSL).
    Weigel R; Senn P; Weis J; Krauss JK
    Clin Neurol Neurosurg; 2004 Mar; 106(2):82-7. PubMed ID: 15003295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 2-methoxyestradiol and methotrexate effects on non-Hodgkin's B-cell lymphoma.
    Park J; Franco RS; Augsburger JJ; Banerjee RK
    Curr Eye Res; 2007; 32(7-8):659-67. PubMed ID: 17852190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
    Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC
    Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged accumulation of high-dose methotrexate in a case with large liver cysts.
    Kawakami M; Omori H; Yamagami T; Soma T
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):619-22. PubMed ID: 19319534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management recommendations in patients with methotrexate intoxication].
    Schellens JH; Beijnen JH
    Ned Tijdschr Geneeskd; 2007 Feb; 151(6):337-41. PubMed ID: 17352296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful treatment of high-dose methotrexate-induced oliguric acute renal failure by using a combination of hemodialysis filtration and direct hemoperfusion].
    Morozumi I; Inagaki A; Suzuki S; Sato Y; Ogura H; Suga N; Komatsu H; Wakita A; Yamada K
    Gan To Kagaku Ryoho; 2015 May; 42(5):609-11. PubMed ID: 25981656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy.
    Bacci G; Ferrari S; Longhi A; Forni C; Loro L; Beghelli C; Tremosini M; Versari M
    Oncol Rep; 2003; 10(4):851-7. PubMed ID: 12792734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset delayed excretion of methotrexate.
    Pauley JL; Panetta JC; Schmidt J; Kornegay N; Relling MV; Pui CH
    Cancer Chemother Pharmacol; 2004 Aug; 54(2):146-52. PubMed ID: 15148625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Toxicosis of high-dose methotrexate (HD-MTX) for osteosarcoma, cured with treatment by leucovorin (LV) rescue and hemoperfusion--a case report].
    Kobayashi H; Morita T; Hirata Y; Kato T; Okada Y; Sato T
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):475-8. PubMed ID: 10740644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [2-year complete remission after withdrawal of methotrexate in a rectal methotrexate-associated diffuse large B-cell lymphoma].
    Ogasawara T; Kimura A; Yasuyama M; Ohtuka K; Aiba M; Kawauchi K
    Rinsho Ketsueki; 2007 Jun; 48(6):485-90. PubMed ID: 17633096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV-associated diffuse large B-cell lymphoma in a psoriatic treated with methotrexate.
    Hsiao SC; Ichinohasama R; Lin SH; Liao YL; Chang ST; Cho CY; Chuang SS
    Pathol Res Pract; 2009; 205(1):43-9. PubMed ID: 18951733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Managing methotrexate toxicity: a case report].
    Fernández Megía MJ; Alós Almiñana M; Terol Castera MJ
    Farm Hosp; 2004; 28(5):371-4. PubMed ID: 15504095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL).
    Skärby T; Jönsson P; Hjorth L; Behrentz M; Björk O; Forestier E; Jarfelt M; Lönnerholm G; Höglund P
    Cancer Chemother Pharmacol; 2003 Apr; 51(4):311-20. PubMed ID: 12721759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P; Oviedo I; Campbell M; Tordecilla J
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.